Home > PS Ratio > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
PS (Price/Sales) Ratio

The Current P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES is 7.70.

Share Price ₹1,522.6Apr 19,2024
Market Cap ₹365,305.4 Cr
Sales-TTM₹47,444.6 CrTTM-Consolidated Results
Price/Sales7.70xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMACEUTICAL INDUSTRIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SUN PHARMACEUTICAL INDUSTRIES is calculated as :

Current Market Cap [ ₹365,305.4 Cr] as on Apr 19,2024

(/) Sales [ ₹47,444.6 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 7.70x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SUN PHARMACEUTICAL INDUSTRIES , the investors are currently willing to pay '7.70 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMACEUTICAL INDUSTRIES !

The chart below summarizes the trend in P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES over the last five years.

Historical PS (Price/Sales) ratio chart of SUN PHARMACEUTICAL INDUSTRIES


PS Ratio Performance Analysis for SUN PHARMACEUTICAL INDUSTRIES

- SUN PHARMACEUTICAL INDUSTRIES 's latest p/e ratio is 7.70x.

- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.37x.

- SUN PHARMACEUTICAL INDUSTRIES 's operated at median p/e ratio of 4.28x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio peaked in Mar2022 at 5.68x.

- SUN PHARMACEUTICAL INDUSTRIES 's p/e ratio hit its five-year low in Mar2020 of 2.57x.


How does SUN PHARMACEUTICAL INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SUN PHARMACEUTICAL INDUSTRIES 47,444.67.70365,305.4
CIPLA LTD25,350.24.28108,623.0
DR REDDYS LABORATORIES LTD27,212.53.6499,134.3
ZYDUS LIFESCIENCES LTD19,024.24.8892,794.9
DIVIS LABORATORIES LTD7,492.813.0097,408.4
MANKIND PHARMA LTD9,946.39.4193,565.4
TORRENT PHARMACEUTICALS LTD10,474.08.2085,858.5
LUPIN LTD19,480.13.6270,506.8
AUROBINDO PHARMA LTD27,894.72.2863,697.4
ABBOTT INDIA LTD5,753.49.6555,528.4
ALKEM LABORATORIES LTD12,634.44.3655,102.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUN PHARMACEUTICAL INDUSTRIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.28x
Max industry PS 13.00x
Median industry PS 4.88x
Average industry PS 6.46x



You may also like the below Video Courses